Efficacy of intravenous immunoglobulins in severe scleromyxedema dysphagia assessed by oesophageal scintigraphy

Clin Exp Rheumatol. 2024 Aug;42(8):1706. doi: 10.55563/clinexprheumatol/2a5goh. Epub 2024 Aug 1.
No abstract available

Publication types

  • Letter
  • Case Reports

MeSH terms

  • Adult
  • Deglutition Disorders* / diagnostic imaging
  • Deglutition Disorders* / drug therapy
  • Deglutition Disorders* / etiology
  • Esophagus / diagnostic imaging
  • Esophagus / pathology
  • Female
  • Humans
  • Immunoglobulins, Intravenous* / administration & dosage
  • Immunoglobulins, Intravenous* / therapeutic use
  • Male
  • Middle Aged
  • Predictive Value of Tests
  • Radionuclide Imaging
  • Scleromyxedema* / complications
  • Scleromyxedema* / diagnostic imaging
  • Scleromyxedema* / drug therapy
  • Severity of Illness Index
  • Treatment Outcome

Substances

  • Immunoglobulins, Intravenous